R
Robert B. Jenkins
Researcher at Mayo Clinic
Publications - 528
Citations - 50358
Robert B. Jenkins is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Glioma & Fluorescence in situ hybridization. The author has an hindex of 108, co-authored 505 publications receiving 45915 citations. Previous affiliations of Robert B. Jenkins include University of California, San Francisco & Uniformed Services University of the Health Sciences.
Papers
More filters
Journal ArticleDOI
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
Edward H. Romond,Edith A. Perez,John Bryant,Vera J. Suman,Charles E. Geyer,Nancy E. Davidson,Elizabeth Tan-Chiu,Silvana Martino,Soonmyung Paik,Peter A. Kaufman,Sandra M. Swain,Thomas M. Pisansky,Louis Fehrenbacher,Leila A. Kutteh,Victor G. Vogel,Daniel W. Visscher,Greg Yothers,Robert B. Jenkins,Ann M. Brown,S. R. Dakhil,Eleftherios P. Mamounas,Wilma L. Lingle,Pamela M. Klein,James N. Ingle,Norman Wolmark +24 more
TL;DR: Tastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide improves outcomes among women with surgically removed HER2-positive breast cancer.
Journal ArticleDOI
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow,Daniel H. Lachance,Annette M. Molinaro,Kyle M. Walsh,Paul A. Decker,Hugues Sicotte,Melike Pekmezci,Terri Rice,Matt L. Kosel,Ivan Smirnov,Gobinda Sarkar,Alissa Caron,Thomas M. Kollmeyer,Corinne Praska,Anisha R. Chada,Chandralekha Halder,Helen M. Hansen,Lucie McCoy,Paige M. Bracci,Roxanne Marshall,Shichun Zheng,Gerald F. Reis,Alexander R. Pico,Brian P. O'Neill,Jan C. Buckner,Caterina Giannini,Jason T. Huse,Arie Perry,Tarik Tihan,Mitchell S. Berger,Susan M. Chang,Michael D. Prados,Joseph L. Wiemels,John K. Wiencke,Margaret Wrensch,Robert B. Jenkins +35 more
TL;DR: The five glioma molecular groups had different ages at onset, overall survival, and associations with germline variants, which implies that they are characterized by distinct mechanisms of pathogenesis.
Journal ArticleDOI
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Lynn C. Hartmann,Daniel J. Schaid,John E. Woods,Thomas P. Crotty,Jeffrey L. Myers,Phillip G. Arnold,Paul M. Petty,Thomas A. Sellers,Jo Johnson,Shannon K. McDonnell,Marlene H. Frost,Robert B. Jenkins +11 more
TL;DR: In women with a high risk of breast cancer on the basis of family history, prophylactic mastectomy can significantly reduce the incidence of Breast cancer.
Journal ArticleDOI
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
Gregory Cairncross,Meihua Wang,Edward G. Shaw,Robert B. Jenkins,David Brachman,Jan C. Buckner,Karen Fink,Luis Souhami,Normand Laperriere,Walter J. Curran,Minesh P. Mehta +10 more
TL;DR: For the subset of patients with 1p/19q codeleted AO/AOA, PCV plus RT may be an especially effective treatment, although this observation was derived from an unplanned analysis.
Journal ArticleDOI
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
Justin S. Smith,Arie Perry,Thomas J. Borell,Hyun K. Lee,Judith R. O'Fallon,Sandra M. Hosek,David W. Kimmel,Allan J. Yates,Peter C. Burger,Bernd W. Scheithauer,Robert B. Jenkins +10 more
TL;DR: Combined loss of 1p and 19q is a statistically significant predictor of prolonged survival in patients with pure oligodendroglioma, independent of tumor grade, and could potentially improve existing strategies for patient stratification and management.